• Carbon

    89.46 Thousand (Tonnes)
  • Waste

    1.77 Thousand (Tonnes)
  • Water

    279 Thousand (Cubic Meters)
  • Energy

    578.71 Thousand (Gigajoules)
  • Revenue

    3,471 Million USD
Rank 7
Rank 19
Rank
SHPGY-O
JE00B2QKY057
UNITED KINGDOM
Health Care
Pharmaceuticals

About Company

Shire Plc (LSE: SHP), (NASDAQ: SHPGY) is a pharmaceutical and biotechnology company with a business focus on attention deficit hyperactivity disorder (ADHD), human genetic therapies (HGT) and gastrointestinal (GI) diseases, as well as opportunities in other therapeutic areas to the extent they arise through acquisitions. The Company engages in the research, development, manufacture, sale, and distribution of pharmaceutical products. Shire Plc targets specialty markets through focused in-licensing, merger and acquisition efforts.

Headquartered in the UK, Shire does most of its business in North America.

Company Website: www.shire.com
Corporate Responsibility Website: Responsibility at Shire

Top Competitors of
Shire PLC

  • Novartis AG

    ESG Rank 6
    Novartis AG (VTX: NOVN, NYSE: NVS) is a Switzerland-based holding that, through its subsidiaries, is engaged in the research, development, manufact..
    Read more...
  • Johnson & Johnson

    ESG Rank 15
    Johnson & Johnson (NYSE: JNJ) is a holding company. The Company and its subsidiaries are engaged in the research and development, manufacture and s..
    Read more...
  • Glaxosmithkline PLC

    ESG Rank 9
    GlaxoSmithKline plc (GSK) (LON: GSK, NYSE: GSK) is global healthcare group, which is engaged in the creation and discovery, development, manufactur..
    Read more...

Subscribe to the
Justmeans ESG Dashboard

A subscription includes full access to Environmental, Social, and Governance Data, company comparisons, ability to share data charts, custom reports, and more.

Learn more...